Medical imaging sits at the center of modern diagnosis. From spotting a fracture to planning a tumor resection, clinicians depend on imaging at almost every stage of care. According to Grand View Research, the medical imaging market is entering a steady growth phase, driven by an aging population, rising chronic disease, and a wave of AI-enabled equipment.

Key Technologies and Modalities

The market spans five major technology groups:

• X-ray devices: radiography, fluoroscopy, and mammography.
• Ultrasound: handheld, compact, and cart/trolley-based systems.
• Computed tomography (CT): high-, mid-, and low-end slice systems, plus cone beam CT.
• Magnetic resonance imaging (MRI): closed and open systems.
• Nuclear imaging: SPECT and PET.

MRI led the market in 2025 with a 27.9% revenue share. It is widely used for the brain, spine, heart, breast, abdomen, and musculoskeletal structures. Advances such as diffusion tensor imaging, perfusion imaging, functional MRI, and intraoperative MRI keep widening its clinical use. Deep learning is also speeding up scans. GE HealthCare's FDA-cleared Sonic DL is one example, enabling high-quality cardiac imaging within a single heartbeat.

CT is the fastest-growing modality. It delivers high-resolution views of organs, tissue, and bone, and newer systems are faster, more accurate, and safer. Cardiac CT is gaining particular momentum, helped by guideline support for coronary CT angiography in evaluating chest pain.

By application, orthopedic imaging held the largest share (32.4%) in 2025, supported by rising bone injuries and road accident trauma. Cardiology is projected to grow fastest.

Want deeper insights? The full Grand View Research report covers 20+ countries, segment-level forecasts, and competitive profiles. Download Free Sample to explore the data and report structure.

Major Growth Drivers

1. An aging global population. Older adults face higher risks of heart disease, stroke, cancer, and osteoporosis, all of which rely on imaging. The UN expects the number of people aged 65 and above to double over the next 30 years, reaching 1.6 billion by 2050.
2. Rising chronic disease burden. In the U.S. alone, an estimated 1.96 million new cancer cases were projected for 2023. The WHO reports roughly 3.6 billion diagnostic tests performed worldwide each year. Surgeons also increasingly rely on preoperative MRI and CT to map tumor margins.
3. Demand for early, accurate diagnosis. Imaging is non-invasive and often preferred over alternatives such as biopsies and blood tests, which gives it a durable advantage.
4. Sustained R&D and investment. Public and private funding is pouring into next-generation systems, from Canon's in-house-built Vantage Galan 3T MRI to United Imaging's USD 490 million R&D and manufacturing campus in Shanghai.

A note on restraints: high equipment cost remains a barrier, particularly in low- and middle-income countries. Providers are responding by evaluating total cost of ownership rather than sticker price alone.

Market Overview & Core Numbers

• Market size, 2025: USD 43.5 billion
• Estimated market size, 2026: USD 45.5 billion
• Projected market size, 2033: USD 64.7 billion
• CAGR, 2026–2033: 5.1%
• Largest region (2025): North America, 36.3% share
• Fastest-growing region: Asia Pacific
• Leading technology: MRI, 27.9% share
• Leading application: Orthopedics, 32.4% share
• Leading end-use: Hospitals, 42.0% share

Regional picture: North America leads thanks to high healthcare spending, strong reimbursement, and heavy chronic disease incidence, and it is expected to keep that position. Asia Pacific should grow fastest, fueled by population growth, expanding R&D, and demand for both conventional and advanced systems. In India, for instance, Philips has expanded its manufacturing and R&D facility in Maharashtra.

End-use picture: Hospitals dominate because they invest heavily in advanced imaging. Diagnostic imaging centers are growing at the highest rate, driven by greater awareness of cancer and neurological conditions and rising CT and MRI volumes.

Dominant Market Trends

AI is becoming the core of the imaging workflow. AI algorithms analyze complex images faster, support early detection, and ease radiologist workload. GE HealthCare's work with Mass General Brigham on foundation models, and its SonoSAMTrack model for ultrasound segmentation, show where the industry is heading. Its acquisition of Caption Health also added AI-guided ultrasound.

Portable and point-of-care imaging is moving care beyond the hospital. Examples include Siemens Healthineers' mobile 1.5T MAGNETOM Viato.Mobile MRI, portable X-ray systems with built-in workstations, and Canon's lightweight Aplio me ultrasound.

Immersive visualization is emerging. Visage Imaging's Visage Ease VP brings diagnostic image review to Apple Vision Pro, and Philips' ClarifEye offers augmented reality surgical navigation.

Consolidation and partnerships are accelerating. Canon acquired NXC Imaging and partnered with Olympus on endoscopic ultrasound, reflecting the industry's push to combine capabilities quickly.

A concentrated, mature, regulated industry. A few major players dominate, innovation is incremental but steady, and stringent FDA and EMA standards make bringing new technologies to market slow and costly.

Key Global Players

The market is led by established names, including:

• GE HealthCare
• Koninklijke Philips N.V.
• Siemens Healthineers
• Canon Medical Systems Corporation
• Mindray Medical International
• FUJIFILM VisualSonics Inc.
• Carestream Health
• Hitachi
• Samsung Medison Co., Ltd.
• Koning Corporation
• PerkinElmer Inc.
• Konica Minolta
• Esaote
• Hologic, Inc.
• Varex Imaging

These companies compete through product launches, AI integration, expansion, and partnerships. Recent examples include Philips' AI-powered CT 3500 for high-volume screening and Canon's new Aquilion ONE / INSIGHT Edition and Aquilion Serve SP CT scanners.

The Road Ahead

With a projected rise from USD 45.5 billion in 2026 to USD 64.7 billion by 2033, medical imaging offers opportunity across modalities, applications, and regions. The winners will be those who pair clinical precision with AI, portability, and cost-conscious design.

Speak to Analyst to discuss how these findings apply to your strategy.